Potency Assessment of Dendritic Cell Anticancer Vaccine: Validation of the Co-Flow DC Assay

For many years, oncological clinical trials have taken advantage of dendritic cells (DC) for the design of DC-based cellular therapies. This has required the design of suitable quality control assays to evaluate the potency of these products. The purpose of our work was to develop and validate a nov...

Descripción completa

Detalles Bibliográficos
Autores principales: Carloni, Silvia, Piccinini, Claudia, Pancisi, Elena, Soldati, Valentina, Stefanelli, Monica, Granato, Anna Maria, Ibrahim, Toni, Petrini, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198694/
https://www.ncbi.nlm.nih.gov/pubmed/34072360
http://dx.doi.org/10.3390/ijms22115824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198694/
https://www.ncbi.nlm.nih.gov/pubmed/34072360
http://dx.doi.org/10.3390/ijms22115824

Ejemplares similares